Published August 2021 | Version v1
Journal article

Radiomics-based model for predicting pathological complete response to neoadjuvant chemotherapy in muscle-invasive bladder cancer

  • 1. Department of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul (Korea, Republic of)
  • 2. Institute for Life Sciences, University of Ulsan College of Medicine, Seoul, 05505 (Korea, Republic of)

Description

Highlights: • Use of radiomics signature may predict pathologic complete response. • Radiomics-based model showed higher net benefit than no model use. • Radiomics-based model provides a tool for optimizing treatment plans. To develop and validate a radiomics-based model for predicting response to neoadjuvant chemotherapy (NAC) using baseline computed tomography (CT) images in patients with muscle-invasive bladder cancer (MIBC).

Availability note (English)

Available from http://dx.doi.org/10.1016/j.crad.2021.03.001

Additional details

Identifiers

DOI
10.1016/j.crad.2021.03.001;
PII
S0009926021001513;

Publishing Information

Journal Title
Clinical Radiology
Journal Volume
76
Journal Issue
8
Journal Page Range
p. 627.e13-627.e21
ISSN
0009-9260
CODEN
CLRAAG

INIS

Country of Publication
United Kingdom
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
54001280
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
BLADDER; CHEMOTHERAPY; COMPUTERIZED TOMOGRAPHY; MUSCLES; NEOPLASMS; OPTIMIZATION; PATIENTS; RADIOMICS
Descriptors DEC
BODY; DIAGNOSTIC TECHNIQUES; DISEASES; MEDICINE; NUCLEAR MEDICINE; ORGANS; RADIOLOGY; THERAPY; TOMOGRAPHY; URINARY TRACT

Optional Information

Copyright
Copyright (c) 2021 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.